a story lives forever
Register
Sign in
Form submission failed!

Stay signed in

Recover your password?
Register
Form submission failed!

Web of Stories Ltd would like to keep you informed about our products and services.

Please tick here if you would like us to keep you informed about our products and services.

I have read and accepted the Terms & Conditions.

Please note: Your email and any private information provided at registration will not be passed on to other individuals or organisations without your specific approval.

Video URL

You must be registered to use this feature. Sign in or register.

NEXT STORY

The evolution of viruses

RELATED STORIES

Lerner and Schultz – making catalysts from antibodies
Manfred Eigen Scientist
Comments (0) Please sign in or register to add comments

In recent time, it was possible to make to make catalysts from antibodies. You know what antibodies are – antibodies are produced in our immune system to fight invaders... to fight invasion by foreign substances. So they are protein molecules of a different structure.  Much work has been done... actually we know it's about the best organ... we know how it functions... the immune system. And now some years ago Richard Lerner at the Scripps [Research] Institute at La Jolla and Peter Schultz at the University of California at Berkeley have used antibodies to make catalysts out of them. That's a very tricky way, because you have to think what does catalysis mean. Catalysis means you change a molecule. That means usually you have to bring it over some activation barrier. And on the top of the barrier, one calls that the transition state, the molecule has to get through this transition state in order to be... to be transformed, and the catalyst helps it to get over this activation barrier. Now the ingenious idea of Lerner and Schultz was to grow antibodies against transition states. Of course, transition state is not a stable state, so they had to use analogue states which had exactly the same structure as a transition state. And by growing antibodies – which is a procedure of a few weeks, to make antibodies – they were able to make pretty potent and efficient catalysts, by just using this trick, growing them against antibody analogues. And they did the same for making a proteolytic enzyme from antibodies, and here again you find the proton relay. So that is in the protein which evolved in the immune system, that means within a few weeks.

So you see, evolution doesn't need millions or billions of year. Whenever you have a clear problem given to the system, whenever you have optimal conditions, that you need in the immune system... Look, our mutation rate in humans is of the order of 10-12, so there's almost no change, otherwise we wouldn't be stable, we would simply disappear. Our genome contains three billion nucleotides, so if we copy our genome, that's from generation to generation, you have to be very precise with that and the error rate has been estimated to be as low as 10-12. But in the immune system you have to produce new substances, you have to optimise them, you have to get the best possible fit in the immune system, there you need high mutation rates and... César Milstein at Cambridge found out that indeed for the somatic mutation in the immune system, the mutation rates are as high as in viruses, so 10-3 to 10-4, and there you can within a short time adapt your proteins to a new job.

Nobel Prize winning German biophysical chemist, Manfred Eigen (1927-2019), was best known for his work on fast chemical reactions and his development of ways to accurately measure these reactions down to the nearest billionth of a second. He published over 100 papers with topics ranging from hydrogen bridges of nucleic acids to the storage of information in the central nervous system.

Listeners: Ruthild Winkler-Oswatitch

Ruthild Winkler-Oswatitsch is the eldest daughter of the Austrian physicist Klaus Osatitsch, an internationally renowned expert in gas dynamics, and his wife Hedwig Oswatitsch-Klabinus. She was born in the German university town of Göttingen where her father worked at the Kaiser Wilhelm Institute of Aerodynamics under Ludwig Prandtl. After World War II she was educated in Stockholm, Sweden, where her father was then a research scientist and lecturer at the Royal Institute of Technology.

In 1961 Ruthild Winkler-Oswatitsch enrolled in Chemistry at the Technical University of Vienna where she received her PhD in 1969 with a dissertation on "Fast complex reactions of alkali ions with biological membrane carriers". The experimental work for her thesis was carried out at the Max Planck Institute for Physical Chemistry in Göttingen under Manfred Eigen.

From 1971 to the present Ruthild Winkler-Oswatitsch has been working as a research scientist at the Max Planck Institute in Göttingen in the Department of Chemical Kinetics which is headed by Manfred Eigen. Her interest was first focused on an application of relaxation techniques to the study of fast biological reactions. Thereafter, she engaged in theoretical studies on molecular evolution and developed game models for representing the underlying chemical proceses. Together with Manfred Eigen she wrote the widely noted book, "Laws of the Game" (Alfred A. Knopf Inc. 1981 and Princeton University Press, 1993). Her more recent studies were concerned with comparative sequence analysis of nucleic acids in order to find out the age of the genetic code and the time course of the early evolution of life. For the last decade she has been successfully establishing industrial applications in the field of evolutionary biotechnology.

Tags: The Scripps Research Institute, La Jolla, University of California, Berkeley, University of Cambridge, catalysis, antibodies, proton relay, somatic mutation, immune system, Richard A Lerner, César Milstein, Peter G Schultz

Duration: 3 minutes, 50 seconds

Date story recorded: July 1997

Date story went live: 24 January 2008